European Society of Retina Specialists (EURETINA) 2022
OAKS and DERBY Phase 3 trials: analyses of pegcetacoplan efficacy in GA due to AMD at 18 months using three different statistical models
Relationship Between Number of Intermediate or Large Drusen and Geographic Atrophy Lesion Growth Rate in the Sham Groups of the OAKS, DERBY, and FILLY Trials
Results of a Delphi Consensus Study of Geographic Atrophy Diagnosis and Current Management
A mixed-methods study of the clinical, humanistic, and economic burden of geographic atrophy (GA) among patients and their unpaid caregivers
Association of Pegcetacoplan Therapy with the Progression of Photoreceptor Degeneration Outside of Geographic Atrophy
The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.